Migraine affects an estimated 280,000 people across Greater Manchester and creates an annual economic and quality-of-life burden of around £870m, according to a report from Health Innovation Manchester and AbbVie UK. The report, based on linked healthcare data, health economic modelling, pathway analysis and patient and healthcare professional insights, estimates that £546m of the burden […]
The post Migraine annual economic and quality-of-life burden in UK appeared first on Pharmafile.